Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example

Author(s):
Landewe, R.B.M.; Smolen, J.S.; Weinblatt, M.E.; Emery, P.; Dougados, M.; Fleischmann, R.; Aletaha, D.; Kavanaugh, A.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 10, p. 1755-1760
hdl
1887/103565
doi
10.1136/annrheumdis-2014-205821